Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7XBJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,857
Award facts
- Contract value 100% obligated
- $5,857.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for XIFAXAN 550 MG Tablet 60s with a ceiling value of $5,857.18.
Place of performance is Conshohocken, PA. The ultimate completion date is February 24, 2026. This is a firm fixed-price delivery order with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F7XBJ?
SPE2DR26F7XBJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 23, 2026.
How much is contract SPE2DR26F7XBJ worth?
The government has obligated $5,857 on SPE2DR26F7XBJ.
Is contract SPE2DR26F7XBJ an order under another contract?
Yes. SPE2DR26F7XBJ is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7XBJ competed?
The extent of competition for SPE2DR26F7XBJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award